“…The WNT/b-catenin signaling pathway, traditionally well known as a regulator of embryonic development, tissue homeostasis, and carcinogenesis, was recently identified as an important endogenous regulator of hepatic drug metabolism in mouse liver, where the activity of this particular pathway determines hepatic zonation of cytochrome P450 (P450) expression (Loeppen et al, 2005;Hailfinger et al, 2006;Sekine et al, 2006;Braeuning and Schwarz, 2010;Braeuning et al, 2011a;Schreiber et al, 2011) and is also critically involved in the regulation of P450 transcription in response to exposure to xenobiotic agonists of a number of nuclear receptors (Braeuning et al, 2009;Ganzenberg et al, 2013;Vaas et al, 2014). Lipid-and xenobiotic-sensing nuclear receptors pregnane X receptor (PXR, NR1I2), constitutive androstane receptor (CAR, NR1I3), and aryl hydrocarbon receptor (AhR), together with the liverenriched transcription factor peroxisome proliferator-activated receptor (PPAR) a (NR1C1) form networks of transcription factors that coordinately regulate hepatic expression of the majority of drug-metabolizing P450s, phase II enzymes, and transporters in response to xenobiotic exposure (Handschin and Meyer, 2005;Pascussi et al, 2008;Pelkonen et al, 2008;Thomas et al, 2013).…”